A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan

NCT00682578 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1086

Enrollment

OTHER

Sponsor class

Conditions

Uncomplicated Falciparum Malaria
Vivax Malaria

Interventions

DRUG: Dihydroartemisinin + Piperaquine (Artekin)
DRUG: artesunate-sulphadoxin/pyrimethamine, chloroquine

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]